Raymond James & Associates’s Krystal Biotech KRYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	$521K	Buy	2,861 +32	+1%	+$5.83K	﹤0.01%	3072
2024 Q2	$520K	Buy	+2,829	New	+$520K	﹤0.01%	3034